|
Product Name |
BAM15 peptide |
|
Appearance |
White to off-white crystalline powder |
|
Assay |
99% by HPLC |
|
Molecular Formula |
C₁₅H₁₀F₄O |
|
CAS Number |
1202401-89-1 |
|
Solubility |
Easy soluble in organic solvents (e.g., DMSO, ethanol). Low solubility in aqueous solutions; typically requires preparation of stock solutions in DMSO. |
|
Storage |
Cool dry place( Store at -20°C, away from the light) Wear appropriate personal protective equipment during operation to avoid inhalation or direct skin contact. |
Products Description
What is BAM15 peptide?
SBAM15 is a synthetic, small-molecule compound that is neither a "polypeptide" nor a "peptide." It functions as a mitochondrial proton carrier uncoupler. By directly targeting mitochondria-the core organelle of cellular energy metabolism-it represents an "energy-depletion" anti-obesity strategy. Despite promising preclinical data, critical questions regarding human safety, long-term side effects, and optimal dosage remain unknown "black boxes." The journey from laboratory to pharmacy remains exceptionally long. Therefore, any current products containing BAM15 are strictly for scientific research purposes only.
Xi 'an Tongze can provide other peptide products, the catalog is as follows, welcome to consult!
|
Product Name |
CAS No. |
|
Goralatide |
127103-11-1/120081-14-3 |
|
ARA-290(Cibinetide) |
1208243-50-8 |
|
N-acetyl Semax Amidate |
2920938-90-3 |
|
N-AC-selank-amidate |
N/A |
|
Aviptadil Acetate |
40077-57-4 |
|
GLP-1(1-37) |
87805-34-3 |
|
GIP (huMan) |
100040-31-1 |
|
N-Acetyl-Semax |
N/A |
|
N-Acetyl Selank |
N/A |
|
S-Phenylacetyl Larazotide |
N/A |
|
Dermorphin |
77614-16-5 |
|
PEG-MGF |
N/A |
|
Met-enkephalin |
58569-55-4 |
|
Pramlintide Acetate |
196078-30-5 |
|
Dalargin |
81733-79-1 |
|
Abaloparatide |
247062-33-5 |
|
N-Acetyl Larazotide |
N/A |
|
Humanin |
330936-69-1 |
|
Adamax |
N/A |
COA of BAM15 peptide
|
Product Name |
BAM15 |
CAS Number |
210302-17-3 |
|
Manufacture Date |
2025/07/03 |
Expiration Date |
2027/07/02 |
|
Batch Number |
TZ20250703 |
Batch Quantity |
2020G |
|
Item |
Specification |
Results |
|
Organoleptic Data |
||
|
Appearance |
Light yellow Powder |
White powder |
|
Odor &Taste |
Characteristic |
Conform |
|
Identification |
H-NMR |
Conform |
|
Solubility |
Soluble in water ≥100mg/m (H2O) |
Conform |
|
PH |
4.0-6.0 |
5.85 |
|
Physical Characteristics |
||
|
Purity (By HPLC) |
≥99.0% |
99.78% |
|
Water Content (Karl Fischer) |
≤0.5% |
0.1% |
|
Residual solvent |
Mlethanol≤0.2% |
No Detected |
|
Acetonitrile≤0.2% |
No Detected |
|
|
Triethylamine≤0.2% |
No Detected |
|
|
Bacterial endotoxin |
<10EU/mg |
<0.1EU/mg |
|
Total mold and yeast count |
<10cfu/g |
Conform |
|
Escherichia coli |
<10cfu/g |
No Detected |
|
Total aerobic bacteria |
<10cfu/g |
Conform |
|
Conclusion |
The product conforms with enterprise standard and qualified |
|
|
Packing |
Keep in dark and cool dry place ,2 to 8°C |
|
|
Storage |
Keep in dark and cool dry place |
|
|
Shelf life |
2 Years When Stored properly |
|
Application of BAM15 peptide
Currently, BAM15 remains in the preclinical research phase. While substantial animal study data exists, it has not yet entered human clinical trials.
Comprehensive toxicology studies are required to confirm its safety for long-term use in humans.
Researchers are exploring combination therapies with BAM15 and other mechanism-based drugs (such as GLP-1 agonists and SGLT2 inhibitors) to achieve synergistic effects, thereby reducing individual dosages and side effects.
Benefits of BAM15 peptide
Primarily validated in preclinical (animal) models:
1. Effectively reduces body weight and body fat: In a high-fat diet-induced obese mouse model, BAM15 significantly reduced body weight, decreased adipose tissue mass, and improved body composition.
2. Improves insulin sensitivity and glycemic control: By promoting substrate oxidation and enhancing metabolic flexibility, it reverses insulin resistance and lowers blood glucose levels.
3. Alleviates non-alcoholic fatty liver disease (NAFLD/NASH): Significantly reduces hepatic steatosis (fatty liver) and mitigates markers of liver inflammation and fibrosis.
4. Enhances systemic metabolic health markers: Includes lowering blood lipids (triglycerides, cholesterol) and reducing chronic low-grade inflammation.
Compared to earlier uncoupling agents such as DNP
1. Tissue-specific propensity:
Studies indicate that compared to DNP, BAM15 may exhibit a greater tendency to accumulate in metabolically active tissues (such as muscle, adipose tissue, and liver) while exerting reduced effects on critical organs like the heart and brain. This potentially lowers the risk of neurotoxicity and cardiotoxicity.
2. Does Not Increase Reactive Oxygen Species (ROS) Production:
A key advantage is that BAM15 does not elevate mitochondrial ROS production during uncoupling. Excessive ROS is a major contributor to cellular damage, inflammation, and many side effects (such as DNP's risk of fever and hyperthermia). This characteristic significantly enhances BAM15's safety profile.
3. Does not stimulate plasma glucagon-like peptide-1 (GLP-1):
Unlike another class of weight-loss drugs (GLP-1 receptor agonists, such as semaglutide), BAM15 does not rely on stimulating insulin or GLP-1 secretion. This opens possibilities for combination therapy or use in specific patient populations.
4. Efficient Fat Reduction Without Affecting Lean Body Mass:
In animal studies, BAM15 effectively reduced fat content while largely preserving muscle mass. This is crucial for achieving ideal weight loss outcomes, as many weight loss methods result in muscle loss.
Statement
BAM15 remains in the preclinical research phase. While substantial animal study data exists, it has not yet entered human clinical trials.
BAM15 represents an emerging strategy to combat obesity and metabolic diseases by "resetting" cellular metabolism. It achieves fat reduction and improved metabolic health without relying on appetite suppression by decoupling mitochondrial respiration from ATP production, thereby forcing the body to burn more fuel. Its design improvements-particularly its minimal impact on ROS production and potential for tissue-specific targeting-offer a higher safety profile compared to previous-generation uncouplers.
While a long path remains before becoming an approved drug, BAM15 presents an attractive new direction for future obesity treatments. It may be particularly well-suited for combination use with existing therapies to achieve more comprehensive and healthier weight and metabolic management.
Packing & Shipping
Why Choose Us
Customer Feedback
CONTACT PAGE
1.Inquiry methods：
Email:alice@xaheshun.com
Whatspp:+8618509260106
Online instant messaging
2.Contact Information：
Name：Alice
Telephone :+8618509260106
Email:alice@xaheshun.com
FAQ
Q: Can we offer Related products of BAM15 Peptide?
A: Yes, We can provide other peptides,welcome to consult.
Q: How do you treat quality complaint ?
A:First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.
Q:Can customized packaging be carried out of BAM15 Peptide?
A:Of course, it can be repackaged. For instance, it is commonly used in vials or freeze-dried powder bottles for beauty purposes. We can provide them all.
Q:Is there a discount?
A:Of course, welcome to contact us. Price would be different based on different quantity. For bulk quantity, we will have discount for you.At the same time, we have a detailed list of discounted products and products with large inventory every quarter.
Q:Whether customized services can be provided
A:We offer ODM/OEM services and can manufacture according to specified formulations. We have our own designers who can design and customize private brands, packaging. Our customized service from the production of raw materials, design of brands/packaging, to the production of customized packaging, and then to packaging, mailing packages, one-stop production line, welcome to visit.
Hot Tags: bam15 peptide, China bam15 peptide manufacturers, suppliers, factory, Dihydroberberine for Fat Burning, Tetrahydrocurcumin for Anti aging, Fenbendazole for Animal Health Care, Berberine HCl for Glucose Regulation, 4 Aminobenzoic Acid, Loratadine for Cold Relief
